Does this optic neuritis patient have neuromyelitis optica? An approach to optic neuritis in the context of neuromyelitis optica
暂无分享,去创建一个
[1] R. Zivadinov,et al. Conventional and Advanced Imaging in Neuromyelitis Optica , 2014, American Journal of Neuroradiology.
[2] P. Calabresi,et al. Differentiating NMO and MS-Associated Optic Neuritis by MRI (S63.002) , 2014 .
[3] A. Falini,et al. Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica , 2014, Annals of neurology.
[4] Y. Lim,et al. First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis , 2014, Neurological Sciences.
[5] David H. Miller,et al. Optic neuritis , 2014, The Lancet Neurology.
[6] F. Costello,et al. An approach to optic neuritis: the initial presentation , 2013 .
[7] S. Jarius,et al. Aquaporin‐4 Antibodies (NMO‐IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature , 2013, Brain pathology.
[8] Fiona Costello,et al. The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis , 2013, ISRN neurology.
[9] Su-Hyun Kim,et al. A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder. , 2013, JAMA neurology.
[10] Axel Petzold,et al. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis , 2013, PloS one.
[11] B. Weinshenker,et al. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study , 2013, The Lancet Neurology.
[12] G. Plant,et al. Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[13] R. Gold,et al. Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. , 2013, JAMA neurology.
[14] H. Hartung,et al. Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses. , 2013, JAMA neurology.
[15] M. Alvarenga,et al. Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica , 2013, Multiple sclerosis.
[16] Su-Hyun Kim,et al. Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels , 2013, Journal of clinical neurology.
[17] Su-Hyun Kim,et al. Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder , 2012, Multiple sclerosis international.
[18] S. Olindo,et al. Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[19] M. Hutchinson,et al. Does natalizumab therapy worsen neuromyelitis optica? , 2012, Neurology.
[20] D. Wingerchuk,et al. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. , 2012, Archives of neurology.
[21] M. Gordon,et al. Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis , 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[22] M. Salvetti,et al. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature , 2012, Multiple sclerosis.
[23] M. Papadopoulos,et al. Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.
[24] Jacqueline A Palace,et al. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? , 2012, Neuroradiology.
[25] F. Paul,et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. , 2012, Archives of neurology.
[26] P. Cabre,et al. Plasma Exchange in Severe Attacks of Neuromyelitis Optica , 2012, Multiple sclerosis international.
[27] Shiv Saidha,et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. , 2012, Brain : a journal of neurology.
[28] F. Paul,et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients , 2012, Journal of Neuroinflammation.
[29] Su-Hyun Kim,et al. Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. , 2011, Archives of neurology.
[30] B. Lam,et al. Impact of rituximab on relapse rate and disability in neuromyelitis optica , 2011, Multiple sclerosis.
[31] B. Weinshenker,et al. Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica , 2011, Neurology.
[32] K. Kyvik,et al. A population-based study of neuromyelitis optica in Caucasians , 2011, Neurology.
[33] Su-Hyun Kim,et al. Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica. , 2011, Archives of neurology.
[34] C. Gieger,et al. Variant screening of the coding regions of MEIS1 in patients with restless legs syndrome , 2011, Neurology.
[35] S. Weigand,et al. Neuromyelitis optica unique area postrema lesions , 2011, Neurology.
[36] R. Raininko,et al. Bilateral and recurrent optic neuritis in multiple sclerosis , 2011, Acta neurologica Scandinavica.
[37] Y. Itoyama,et al. Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis. , 2011, The Tohoku journal of experimental medicine.
[38] Axel Petzold,et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis , 2010, The Lancet Neurology.
[39] Jacqueline A Palace,et al. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. , 2010, Archives of neurology.
[40] Brigitte Wildemann,et al. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance , 2010, Nature Reviews Neurology.
[41] T. Nakazawa,et al. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[42] D. Wingerchuk. Neuromyelitis optica: Effect of gender , 2009, Journal of the Neurological Sciences.
[43] B. Weinshenker,et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. , 2009, Archives of neurology.
[44] P. Calabresi,et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies , 2009, Neurology.
[45] K. Trinkaus,et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis , 2009, Neurology.
[46] B. Weinshenker. Neuromyelitis optica in western countries: Establishing diagnostic criteria and characterization of the spectrum , 2008 .
[47] M. Gotkine. Neuromyelitis optica and the Optic Neuritis Treatment Trial. , 2008, Archives of neurology.
[48] Craig H. Smith. Neuromyelitis Optica and the Optic Neuritis Treatment Trial—Reply , 2008 .
[49] Aaron E Miller,et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. , 2008, Archives of neurology.
[50] J. Kurtzke,et al. Characteristics of Devic's disease (neuromyelitis optica) in Mexico , 2008, Journal of Neurology.
[51] Yasuto Itoyama,et al. Preferential spinal central gray matter involvement in neuromyelitis optica , 2008, Journal of neurology.
[52] A. Bar-Or,et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders , 2008, Neurology.
[53] B. Weinshenker,et al. The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.
[54] S. Olindo,et al. Natural history of the visual impairment of relapsing neuromyelitis optica. , 2007, Ophthalmology.
[55] Y. Matsumoto,et al. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination , 2007, Journal of the Neurological Sciences.
[56] M. Ramanathan,et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). , 2006, Archives of neurology.
[57] B. Weinshenker,et al. Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.
[58] L. Balcer. Clinical practice. Optic neuritis. , 2006, The New England journal of medicine.
[59] Y. Itoyama,et al. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica , 2005, Neurology.
[60] A. Bar-Or,et al. Neuromyelitis optica with hypothalamic involvement , 2005, Multiple sclerosis.
[61] E. Waubant,et al. An open label study of the effects of rituximab in neuromyelitis optica , 2005, Neurology.
[62] A. Ghezzi,et al. Devic’s neuromyelitis optica: clinical features and prognostic factors , 2004, Neurological Sciences.
[63] A. Verier,et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile , 2002, Journal of the Neurological Sciences.
[64] P. Cabre,et al. MS and neuromyelitis optica in Martinique (French West Indies) , 2001, Neurology.
[65] A. Minagar,et al. Treatment of Devic's Disease with Methotrexate and Prednisone , 2000 .
[66] B. Weinshenker,et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease , 1999, Annals of neurology.
[67] P C O'Brien,et al. The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.
[68] R. Mandler,et al. Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine , 1998, Neurology.
[69] Neil R. Miller,et al. A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .
[70] Popescu B. F. Gh.,et al. 視神経脊髄炎のユニークな最後野病変: 悪心,嘔吐,および病理発症の意味 , 2011 .
[71] J. Leavitt. NMO-IgG detected in CSF in seronegative neuromyelitis optica , 2010 .
[72] Patrick Vermersch,et al. Neuromyelitis optica and non organ-specific autoimmunity. , 2008, Archives of neurology.
[73] M. Nakamura M. D.,et al. Preferential spinal central gray matter involvement in neuromyelitis optica , 2008, Journal of Neurology.
[74] L. Thuler,et al. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. , 2008, Archives of ophthalmology.
[75] Massimo Filippi,et al. Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica , 2004, Journal of Neurology.
[76] D. Goodin,et al. Neuromyelitis Optica , 2002, Seminars in neurology.